# Hutchmed (HCM) — Analyst Forecast

HCM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/hcm/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jul 23, 2026 | Goldman Sachs | Maintained | Neutral | $14.00 |
| Jul 7, 2026 | B of A Securities | Maintained | Buy | $17.00 |
| Mar 10, 2026 | B of A Securities | Maintained | Buy | $20.00 |
| Sep 22, 2025 | Morgan Stanley | Downgraded | Equal-Weight → Underweight | $13.75 |
| Jul 22, 2025 | B of A Securities | Maintained | Buy | $28.00 |
| Aug 1, 2024 | Goldman Sachs | Maintained | Neutral | $19.00 |
| Nov 24, 2023 | Deutsche Bank | Upgraded | Hold → Buy | $22.10 |
| Nov 10, 2023 | Goldman Sachs | Maintained | Neutral | $17.00 |
| Sep 5, 2023 | Cantor Fitzgerald | Maintained | Overweight | $50.00 |
| Jul 24, 2023 | Cantor Fitzgerald | Maintained | Overweight | $50.00 |

## Frequently Asked Questions

### What is the latest analyst rating on HCM?

On Jul 23, 2026, Goldman Sachs maintained Hutchmed at Neutral with a price target of $14.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).